Brickell Biotech Inc.

04/16/2021 | Press release | Distributed by Public on 04/16/2021 08:05

Brickell Biotech Announces Presentation of US Phase 3 Open-Label Long-Term Safety Study Results for Sofpironium Bromide Gel at the Late-Breaking Research Program during[...]